News Cisen Pharmaceutical Co., Ltd.

Equities

603367

CNE100002VG4

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
16.03 ^CNY	+1.20%		+5.18%	+9.49%

Apr. 23	Cisen Pharmaceutical Names Chief Financial Officer	MT
Apr. 22	Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cisen Pharmaceutical Names Chief Financial Officer	Apr. 23	MT
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Cisen Pharmaceutical Scraps Unit Spin-Off Plan	Dec. 01	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) added to S&P Global BMI Index	23-09-18	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Cisen Pharmaceutical to Spin Off Unit for Shenzhen Float	23-06-09	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Cisen Pharmaceutical Secures Regulatory Approval for Methylcobalamin Tablets	22-11-22	MT
Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs	22-11-17	MT
Cisen Pharma Gets Regulatory Nod For Flu Drug's China Clinical Trial	22-11-09	MT
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-17	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Shijiazhuang No.4 Pharmaceutical Co., Ltd. completed the acquisition of 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke.	21-12-30	CI
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) dropped from S&P Global BMI Index	21-12-20	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Sichuan Kelun Pharmaceutical Co., Ltd. completed the acquisition of 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership).	21-09-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cisen Pharmaceutical Co., Ltd.

Equities

603367

CNE100002VG4

Summary

Filters